FlowCardia, Inc. Introduces First Products to Market and Delivers Clinical Update on the FACTOR U.S. Pivotal Trial
January 5, 2006 Categories: Uncategorized Posted by adminFlowCardia, Inc. today announced U.S. 510K clearance and immediate market release of the VP Wire and VP Sheath product families. The company also delivered an encouraging progress report on their U.S. pivotal trial.
The new VP Wire and VP Sheath are designed to facilitate the introduction and navigation of balloon catheters and other interventional devices in PTA and PTCA procedures. The highly supportive 0.014″ VP Wire will be available in 165cm and 300cm lengths in a Soft and Standard platform. The VP Sheath is a thin-walled 6 French catheter that can be introduced through any 8F (0.086″ ID) guide catheter or sheath creating an extended, supportive pathway for interventional devices.
